Arch Therapeutics Inc (QB)【ARTH】株式ニュース

	リアルタイム株価	レベル2
Forex

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Current Report Filing (8-k)

false 0001537561 0001537561 2023-06-15 2023-06-15 UNITED...

Quarterly Report (10-q)

0001537561 false --09-30 2023 Q2 1 3 0 0 0 0 5 7 5 8 4 248 35 200 00015375612022-10-012023-03-31 thunderdome:item iso4...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

false 0001537561 0001537561 2023-04-15 2023-04-15 UNITED...

Current Report Filing (8-k)

false 0001537561 0001537561 2023-03-10 2023-03-10 UNITED STATES SECURITIES AND...

Current Report Filing (8-k)

false 0001537561 0001537561 2023-03-09 2023-03-09 UNITED...

Current Report Filing (8-k)

false 0001537561 0001537561 2023-03-07 2023-03-07 UNITED STATES...

Current Report Filing (8-k)

false 0001537561 0001537561 2023-02-14 2023-02-14 UNITED STATES SECURITIES AND...

Quarterly Report (10-q)

0001537561 false --09-30 2023 Q1 1 5 1 5 8 248 142 00015375612022-10-012022-12-31 thunderdome:item iso4217:USD 0001537561us...

Amended Statement of Ownership (sc 13g/a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Securities Registration Statement (s-1/a)

0001537561 true 3 8.33 2 0 0 1 5 1 5 8 248 00015375612021-10-012022-09-30 thunderdome:item iso4217:USD 00015375612021-09-30...

zino 2月前

DTC Low Floats are the PinkSheet runners lately

👍️0

zino 2月前

$ARTH DTC Shares Just 1.37 Million...
https://x.com/gus94202612/status/1840203380335001974

What happened to going onto Nasdaq?

👍️0

moneymaker290 5月前

Anyone know what these filings r for??

👍️0

Snowy_Owl 7月前

I'm old enough to remember when an announcement like this excited me.

Arch Therapeutics will present AC5 again at the spring Symposium on Advanced Wound Care on May 14-18. CEO Terry Norchi said: “Prior presentations at SAWC included a case of limb salvage in a 32 year-old patient with a necrotic spider-bite; management of post-Mohs surgery wounds; and treatment of recalcitrant wounds that previously failed to respond to other modalities. Clinicians manage a broad array of acute and chronic challenging wounds, often in patients with concurrent medical problems that interfere with healing.”

👍️0

blackngold63 9月前

The float is over a million shares and only $1,373 worth of stock changed hands today.
Less than the price of one of Norchi's suits. Amazing.

👍️0

moneymaker290 9月前

Latest report,,,TOTAL REVENUE for 2023 was $45,800 or $3,800 per month. Let me repeat,,total REVENUE, $45,800 for the YEAR....how can this guy, Terry not end up is Prison,,,,how can anyone continue to loan him money...

👍️0

moneymaker290 10月前

That was the longest report I have ever read...talked 95% about years past...I never did see sales...???

👍️0

moneymaker290 10月前

Unfortunately, will go towards zero....Terry has made himself a great living for years, by milking this company

👍️0

Snowy_Owl 11月前

I wonder if December Medicare/Medicaid sales dropped.

If I’m wrong please correct me, if ARTH can’t hold $4 isn’t the up listing off the table?

👍️0

SriMaharaj 11月前

It will continue to go up from here with anticipation of very good news.

👍️0

Long Duk Dong 11月前

Nice rebound today, still has legs!

👍️0

moneymaker290 12月前

He sees the writing on the wall...this company will be dark soon. I'm sad to say...Poorly run for years, but CEO has made out quite well...

👍️0

Snowy_Owl 12月前

VP of Sales, Dan Yrigoyen, resigned. He was expensive. The position did not seem to be a good fit.

I have no idea if this influenced the most recent drop in share price.

👍️0

moneymaker290 12月前

This POS is unfortunately showing its true colors..

👍️0

Long Duk Dong 12月前

SP getting killed today!

👍️0

Snowy_Owl 12月前

"Once it cross 11 then it will move fast."

It's more important to me how far it will move rather than how fast. Factoring in the most recent 1-for-200 reverse stock split the share price has what I think is an unfeasibly long row to hoe before I'm close to breaking even.

👍️0

SriMaharaj 12月前

Once it cross 11 then it will move fast. We should be hearing soon on moving stock to upper stock exchange soon.

👍️0

SriMaharaj 12月前

Going up. Huge bid. People want to get in before it goes on Nasdaq.

👍️ 1

SriMaharaj 12月前

Wow. 12K+ volume in 5 minutes of opening. Selling done. Time to buy and take it to next high level.

👍️0

SriMaharaj 12月前

It did hold 10 today. This tells me that it will be 20+ tomorrow.

👍️0

JDT72 12月前

That is my hope for sure, today was wild and hard to hold through that run.

👍️0

SriMaharaj 12月前

They are going on Nasdaq in Jan 2024. This could be the reason they asked for advance. I believe float is locked and going to fly to the moon before goes into Nasdaq.

👍️0

JDT72 12月前

New to this site, started following ARTH based on Zacks ranking them as a Strong Buy and their top scoring stock for their combined ranking of value/growth/momentum. I am a bit concerned by the history of them and the recent $250K Shareholders Advance taken on 11/29.

👍️0

SriMaharaj 12月前

wow. With only 100K it's going to 100%+. What will happen if this has 500K volume. I believe it will reach $100 with that volume. No shares available.

👍️0

Long Duk Dong 12月前

Another beauty day for ARTH!

Searching and seaching for one simple answer: WHAT THE HELL IS GOING ONE?????

👍️0

SriMaharaj 1年前

wow, second round has started. It will cross $10 this time.

👍️0

Snowy_Owl 1年前

I think the Lazarus moment is because ARTH was given an extension until early January 2024 to up list and this may be viewed by some as a positive that will take a future reverse split off the table.

I'm not excited by the current stock price as I think it has some characteristics of a pump 'n dump.

👍️0

blackngold63 1年前

Have no idea what is going on. Appears to have risen from the Dead with no news and relatively small volume.

No posts on this board for months, the pps explodes in the last weeks..... and.....Silence.

👍️0

Snowy_Owl 1年前

Anyone else notice the share price has been .666 for some time now? Weird.

👍️0

moneymaker290 1年前

You are Correct..imho

👍️0

blackngold63 1年前

This is Norchi's retirement plan.
He has screwed this up so much he knows he can never get another job in the industry so he will milk this as long as he can.

👍️0

moneymaker290 1年前

I am sad to say I've been in the stock for 8 years at least he doesn't know his butt from first base talking about Norchi... he knows how to keep the company afloat so he can get that huge paycheck every month. That's all this is about now

👍️0

Snowy_Owl 1年前

I'm not qualified to judge the legality of Norchi's actions but I do feel I am qualified to assess this most recent action as blatantly underhanded.

"What Norchi has done and continues to do HAS to be illegal,don't u think"

👍️0

moneymaker290 1年前

What Norchi has done and continues to do HAS to be illegal,,don't u think

👍️0

Snowy_Owl 1年前

Arch Therapeutics has been pretty much over for me for awhile now. Recent actions have eliminated any remaining doubts I may have had.

ARTH dropped 31% on Thursday 9/7/23 after a series of SEC filings. On September 1 they filed a Form 14C informing us that certain actions were taken by the written consent of the holders of a majority of the outstanding voting stock in lieu of a meeting. They increased the number of authorized shares of stock from 12,000,000 to 350,000,000 shares. Then said the Board can approve another reverse split between 1-for-1.5 and 1-for-20.

On September 6 they filed an 8-K to amend the convertible notes to extend the date of the required up list to NASDAQ from August 31 to September 30. That means another reverse split is imminent because they need a stock price over $4 to up list.

In the future, anytime I get a whiff of a stock contemplating a reverse split I am selling what I own, walking away, and never looking back.

👍️0

moneymaker290 1年前

POS keeps going down. There is no what that a crime has been committed by Norchi...personal cash reagistar

👍️0

moneymaker290 1年前

13G filed today..anyone know who this is for

👍️0

Polyphemus 1年前

Currently extending maturity of financing until a new exchange listing (July). $4M market cap for the last decade. Commercial since 2019

👍️0

blackngold63 2年前

All things considered, the stock price is actually holding up well.
No money coming in, no prospect of any money coming in, and yet it has been fairly stable.
I was sure it would be down to a buck by now.

👍️0

moneymaker290 2年前

This has always been just a money machine for CEO Terry N...isn't that against the law??

👍️0

Polyphemus 2年前

Inventory - 88% of assets; 3-mo revenue of $16K, increase of SG&A of $43K

👍️0

Snowy_Owl 2年前

10Q will be filed late.

“ PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Arch Therapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 by the prescribed due date without unreasonable effort or expense because of the circumstances described below.

“The Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023, cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Quarterly Report on Form 10-Q, including the XBRL (eXtensible Business Reporting Language) Interactive Data Files for the financial statements and notes included in the Quarterly Report. The Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 will be filed on or before the 5th calendar day following the prescribed due date.”

👍️0

Polyphemus 2年前

Waiting for revenue numbers instead of conference presentations. Expect to have major inventory write-off in the not so distant future. Exec comp will probably exceed R&D and sales expenses combined.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター